Types of targeted PrEP messaging needed for MSM and health care providers by subgroup.

<p>ARV, antiretroviral medication; MSM, men who have sex with men; PrEP, pre-exposure HIV prophylaxis.</p

Sociodemographic and risk behavior characteristics, N = 1,028.

<p>Sociodemographic and risk behavior characteristics, N = 1,028.</p

Maps of HCV infections by neighborhoods.

<p>Maps of HCV infections by neighborhoods.</p

Phylogenetic analysis.

<p>Phylogenetic analysis.</p

HCV infection outcomes based on HIV status, N = 1,028.

<p>HCV infection outcomes based on HIV status, N = 1,028.</p

.zip archive

Primers, alignments, BEAST xml input files, and results file

Model features.

<p>Model features.</p

Per-act infectivity by time since infection, during acute stage (<b>Figure 1a</b>) and AIDS state (<b>Figure 1b</b>).

<p>For more information on the derivation, see the online technical supplement.</p

Distribution of transmission events by key variables.

<p>Bars represent the means across ten stochastic simulations over 25 years. The variance of these estimates across runs was less than 2 percentage points for all measures, so only means are shown. For year-on-year variation, see the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0050522#pone-0050522-g003" target="_blank">Figure 3</a> and the online technical supplement.</p

Range of variation from year to year for outcome metrics.

<p>Each boxplot covers the values for a given outcome metric measured for each of the 25 years in a single run. We show US Model 1 here as demonstration; comparable plots for the other three country/model combinations are in the online technical supplement.</p